Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001214659-25-002314·PMV Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
PMV PHARMACEUTICALS INC
Common stock, par value $0.00001 per share · CUSIP: 69353Y103
Event date: 2024-12-31
- Filing-level shares
- 3,572,167.00
- Percent of class
- 6.90%
- Sio Capital Management, LLC
Shares: 3,572,167.00 · Class: 6.90%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-002314
- Form type
- SCHEDULE 13G
- Filer
- PMV Pharmaceuticals, Inc.
- CIK
- CIK 1699382
- Filed
- Feb 10, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership